Meijer Allergy Relief (Perrigo) – Impurity Specifications (2021)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, packaged as a) 15 count bottle, NDC 41250-060-22 UPC 7 60236 18716 5; b) 30 count bottle, NDC 41250-060-39, UPC 7 60236 18717 2; c) 45 count bottle, NDC 41250-060-95, UPC 7 60236 18732 5; Made in the Czech Republic, Distributed by Meijer Distribution Inc, Grand Rapids, MI 49544.
Brand
Perrigo Company PLC
Lot Codes / Batch Numbers
Lot a) 0HE2530, Exp 12/31/2021, 0KE2430, Exp 2/28/2022 b) 0LR0362, Exp 6/30/2022, 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022
Products Sold
Lot a) 0HE2530, Exp 12/31/2021; 0KE2430, Exp 2/28/2022 b) 0LR0362, Exp 6/30/2022; 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022
Perrigo Company PLC is recalling Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, packaged as a due to Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026